By CH Unnikrsihnan Drug maker and researcher Glenmark Pharmaceuticals Ltd's new biological drug candidate Bi-Specific ...
NICE has recommended obinutuzumab with mycophenolate for severe lupus nephritis after trials showed higher renal response and fewer flares.
Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
Amid a surprisingly severe flu season and a Covid-19 resurgence, those highly contagious respiratory illnesses are drawing ...
Acceptance of respiratory syncytial virus (RSV) immunizations in the United States is growing, particularly for older adults, ...
Amid a surprisingly severe flu season and a COVID-19 resurgence, those highly contagious respiratory illnesses are drawing ...
A look at the clinical progress of anti-Aβ monoclonal antibodies and how precision delivery is shaping the next generation of ...
A multidisciplinary team has uncovered a key mechanism that allows the human bacterium Mycoplasma pneumoniae—responsible for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results